Efficacy of Add – On Vildagliptin Therapy to Metformin for Type Ii Diabetes Mellitus Patients in South Indian Resource Limited Settings – Pilot Study

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2019English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

To Evaluate the Therapeutic Efficacy of Vildagliptin on Microalbuminuria in Type 2 Diabetes Mellitus

International Journal of Contemporary Medical Research [IJCMR]
2019English

Delivery of Radiation Therapy in Resource-Limited Settings: A Pilot Quality Assessment Study

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2017English

Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients With Type 2 Diabetes: The China Prospective Diabetes Study

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy